Intravitreal ranibizumab in diabetic macular edema;Doszklistkowe iniekcje ranibizumabu w leczeniu cukrzycowego obrzçku plamki

Klinika Oczna

Volumn 112, Issue 10-12, 2010, Pages 333-336

  Kubicka Trza̧ska, Agnieszka ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Diabetic macular edema; Ranibizumab

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; RANIBIZUMAB;

DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RETINA MACULA EDEMA; REVIEW; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 79956293847     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Klein R, Klein R, Klein BE, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998, 105, 1801-1815. (Pubitemid 28509717)
2. Hardy RA, Crawford JB: Retina, [w] General Ophthalmology, str. 178-199, wydanie 15, Appleton and Lange, 1999.
3. Klein R: Retinopathy in a population-based study. Trans Am Ophthalmol Soc 1992, 90, 561-594.
4. Bresnick GH: Diabetic macula edema: a review. A critical review highlighting diffuse macular edema. Ophthalmology 198, 90, 989-997.
5. Moore J, Bagley S, Ireland G, McLeod D, Boulton M: Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat 1999, 194, 89-100. (Pubitemid 29126698)
6. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J, Zimmer-Galler I, Do DV, Campochiaro PA: Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006, 142, 961-969.
7. Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA: Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004, 45, 617-624. (Pubitemid 38140522)
8. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW: Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occluding and zonula occluden. I. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999, 274, 23463-23467.
9. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994, 112, 1476-1482. (Pubitemid 24350514)
10. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331, 1480-1487. (Pubitemid 24356306)
11. Adamis AP, Miller JW, Bernai MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118, 445-450. (Pubitemid 24307211)
12. Vinores SA, Youssri Al, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA: Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997, 12, 99-109.
13. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103, 1820-1828. (Pubitemid 26403735)
14. Funatsu H, Yamashita H, Noma H: Aqueous humor levels of cytokines are related to viterous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005, 243, 3-8.
15. The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. EDTRS Report No. 1. Arch Ophthalmol 1985, 103, 1796-1806.
16. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP: Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology 2007, 114, 2162-2167.
17. Vasconcelos-Santos DV, Nehemy PG, Schachat AR Nehemy MB: Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina 2008, 28, 573-580. (Pubitemid 351589567)
18. Fraser-Bell S, Kaines A, Hykin PG: Update on treatments for diabetic macular edema. Curr Opin Ophthalmol 2008, 19(3), 185-189. (Pubitemid 351535912)
19. Gandorfer A, Messmer EM, Ulbig MW, Kampik A: Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina 2000, 20, 126-133. (Pubitemid 30395706)
20. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE: Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996, 121, 405-413. (Pubitemid 26113283)
21. Figueroa MS, Contreras I, Noval S: Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 2008, 28, 420-426. (Pubitemid 351354942)
22. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ: Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006, 26, 5-13. (Pubitemid 44391745)
23. Chun DW, Heier JS, Trexler MT, Duker JS, Bankert JM: A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macu-lar edema. Ophthalmology 2006, 113, 1706-1712.
24. Ciulla TA, Rosenfeld PJ: Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related ma-cular degeneration. Curr Opin Ophthalmol 2009, 20(3), 166-174.
25. Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro PA: READ-2 Study Group: Primary End Po-int (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study. Ophthalmology 2009 (pra-ça w druku).